Biotech startup String Bio raises Rs 160 crore from investors
New Delhi: Biotech startup String Bio on Monday said it has raised USD 20 million (nearly Rs 160 crore) in a round of funding from investors, including Woodside Energy Group, Ankur Capital, Dare Ventures, Redstart and Zenfold Ventures.
The company has also signed a strategic development agreement with Woodside Energy Technologies Pty Ltd, a wholly-owned subsidiary of Woodside Energy Group, for production of sustainable protein ingredients from greenhouse gases, String Bio said in a statement.
The startup leverages advances in biology, fermentation technology, chemistry and process engineering to convert the energy in methane into diverse value-added products.
Products enabled by String's platform range from protein ingredients for nutrition, to innovative crop inputs and products for biodegradable polymers, the company said.
String had set up its first multi-purpose gas fermentation facility in Bengaluru that can run on methane from both natural gas and biogas.
Read also: Innova Captab files IPO papers with SEBI
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.